Research confirms trusted sources key to vaccination program success
Vaccines | Opinion | 2 Comment | 24 May, 2021
Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...Read more
Singapore extends use of Pfizer-BioNTech COVID-19 vaccine to adolescents
Vaccines | News | 0 Comment | 19 May, 2021
The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...Read more
Australia to soon roll-out single-dose COVID-19 vaccine
Vaccines | News | 0 Comment | 17 May, 2021
A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....Read more
Moderna to supply 25 M vaccine doses to Australia
Vaccines | News | 0 Comment | 14 May, 2021
Moderna, Inc., has announced a new supply agreement with the government of Australia for 25 million doses. Thi...Read more
Fosun, BioNTech invest $200 M to manufacture COVID-19 vaccine in China
Vaccines | News | 0 Comment | 12 May, 2021
Shanghai Fosun Pharma has signed a Joint Venture with BioNTech to manufacture mRNA vaccine in China. The JV will ha...Read more
EU inks the third contract with BioNTech/Pfizer securing 1.8 billion doses
Vaccines | News | 0 Comment | 11 May, 2021
The European Commission has approved a contract for 1.8 billion doses of the BioNTech/Pfizer vaccine. The contract cove...Read more
US approves Pfizer-BioNTech COVID-19 Vaccine for adolescents
Vaccines | News | 0 Comment | 11 May, 2021
The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech C...Read more
Australia's CSIRO suggests nasal delivery of Oxford-AZ vaccine to improve efficacy
Vaccines | News | 0 Comment | 11 May, 2021
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...Read more
China focuses on next-generation intranasal COVID-19 vaccines
Vaccines | News | 0 Comment | 10 May, 2021
COVID-19 infections continue to rise with several countries facing second-and third-wave infections with the newly evolv...Read more
WHO lists China's Sinopharm COVID-19 vaccine for emergency use
Vaccines | News | 0 Comment | 10 May, 2021
The World Health Organisation (WHO) has listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light ...Read more
Oxford’s malaria vaccine shows significant 75% efficacy in early trial
Vaccines | News | 0 Comment | 04 May, 2021
A malaria vaccine created by scientists at the University of Oxford’s Jenner Institute has been found to be 77% ef...Read more
WHO issues emergency use listing to Moderna COVID-19 vaccine
Vaccines | News | 0 Comment | 01 May, 2021
Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...Read more
UK to host global fund-raising summit with CEPI to accelerate vaccine development
Vaccines | News | 0 Comment | 03 May, 2021
Plans to speed up vaccine development to prevent future pandemics and save lives will be boosted by a UK-hosted summit t...Read more
Thailand accelerates production of AstraZeneca COVID-19 vaccine
Vaccines | News | 0 Comment | 30 Apr, 2021
Thailand's Food and Drug Administration (FDA) has approved Siam Bioscience as a manufacturing facility for COV...Read more
Zuellig Pharma partners with Moderna to supply COVID-19 vaccine in Asia
Vaccines | News | 0 Comment | 29 Apr, 2021
Zuellig Pharma, a Singapore based healthcare services provider in Asia, and Moderna, Inc., a US based biotechnology...Read more
RNAimmune accelerates R&D into mRNA vaccine, drug discovery
Vaccines | News | 0 Comment | 23 Apr, 2021
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...Read more
Australia announces $50 M investment in mRNA vaccine manufacturing
Vaccines | News | 0 Comment | 21 Apr, 2021
The Victorian Government’s $50 million investment in mRNA vaccine manufacturing is welcome recognition of the worl...Read more
Moderna announces new supply agreement with Israel for 2022
Vaccines | News | 0 Comment | 22 Apr, 2021
Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...Read more